Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome

Abstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indica...

Full description

Bibliographic Details
Main Authors: Tamer Mohamed Zaalouk, Zouheir Ibrahim Bitar, Ossama Sajeh Maadarani, Mohamed Elsayed Elhabibi
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.3509
id doaj-114078d52fed4d0b95de4ae639ca5ab5
record_format Article
spelling doaj-114078d52fed4d0b95de4ae639ca5ab52021-05-21T11:05:45ZengWileyClinical Case Reports2050-09042021-01-019125625910.1002/ccr3.3509Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndromeTamer Mohamed Zaalouk0Zouheir Ibrahim Bitar1Ossama Sajeh Maadarani2Mohamed Elsayed Elhabibi3Critical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitCritical Care Unit Ahmadi Hospital Kuwait Oil Company Ahmadi KuwaitAbstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome.https://doi.org/10.1002/ccr3.3509carbamazepinemast cell activation syndromemethotrexateStevens‐Johnson syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Tamer Mohamed Zaalouk
Zouheir Ibrahim Bitar
Ossama Sajeh Maadarani
Mohamed Elsayed Elhabibi
spellingShingle Tamer Mohamed Zaalouk
Zouheir Ibrahim Bitar
Ossama Sajeh Maadarani
Mohamed Elsayed Elhabibi
Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
Clinical Case Reports
carbamazepine
mast cell activation syndrome
methotrexate
Stevens‐Johnson syndrome
author_facet Tamer Mohamed Zaalouk
Zouheir Ibrahim Bitar
Ossama Sajeh Maadarani
Mohamed Elsayed Elhabibi
author_sort Tamer Mohamed Zaalouk
title Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_short Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_full Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_fullStr Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_full_unstemmed Carbamazepine‐induced Stevens‐Johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
title_sort carbamazepine‐induced stevens‐johnson syndrome in a patient with history of methotrexate‐induced mast cell activation syndrome
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-01-01
description Abstract Stevens‐Johnson syndrome (SJS) is serious conditions that happen as a result of infection, side effects to medications, or unknown etiology. Carbamazepine is one of the common medications that can cause SJS. Good history taking is crucial if treatment with carbamazepine is clinically indicated. We would like to alert all physicians that carbamazepine should be avoided in any patient with a previous history of drug reaction such as mast cell activation syndrome.
topic carbamazepine
mast cell activation syndrome
methotrexate
Stevens‐Johnson syndrome
url https://doi.org/10.1002/ccr3.3509
work_keys_str_mv AT tamermohamedzaalouk carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT zouheiribrahimbitar carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT ossamasajehmaadarani carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
AT mohamedelsayedelhabibi carbamazepineinducedstevensjohnsonsyndromeinapatientwithhistoryofmethotrexateinducedmastcellactivationsyndrome
_version_ 1721432163653517312